Drugs / Alpha-type-1 Polarizing Dendritic Cells (aDC1)
Alpha-type-1 Polarizing Dendritic Cells (aDC1)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05786937 | Jun → Dec 2023 | — | University of Sao Paulo General Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alpha-type-1 Polarizing Dendritic Cells (aDC1) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05786937 ↗ |
| Modality | Cell therapy | “Dendritic cell based immunotherapy” NCT05786937 ↗ |